Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy? A Multicenter, Randomized, Controlled Trial
Autor: | Elena Martín-Pérez, B. Sánchez-Pérez, Gonzalo Suarez-Artacho, Dimitri Dorcaratto, Esteban Cugat, Santiago López-Ben, A. Serrablo, Alberto Carabias, Paula Senra-Del-Rio, M. Serradilla, Elia Pérez-Aguirre, Maria Isabel Garcia-Domingo, Julio Santoyo-Santoyo, Luis Sabater, Elena Muñoz-Forner, Constantino Fondevila, Jose Maria Jover-Navalon, Javier Padillo, Marina Garcés-Albir, Marcello Di Martino, Luis Díez-Valladares, Mari Carmen Gómez-Mateo, Antonio Ferrández, Fabio Ausania, Laia Falgueras-Verdaguer |
---|---|
Rok vydání: | 2019 |
Předmět: |
medicine.medical_specialty
business.industry Treatment outcome law.invention 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Randomized controlled trial Multicenter study law 030220 oncology & carcinogenesis medicine 030211 gastroenterology & hepatology Surgery Neoplasm staging Radiology business Survival analysis R0 resection Histological examination Artery |
Zdroj: | ANNALS OF SURGERY r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname Digital.CSIC. Repositorio Institucional del CSIC |
ISSN: | 1528-1140 0003-4932 |
Popis: | [Objective]: To compare the rates of R0 resection in pancreatoduodenectomy (PD) for pancreatic and periampullary malignant tumors by means of standard (ST-PD) versus artery-first approach (AFA-PD). [Background]: Standardized histological examination of PD specimens has shown that most pancreatic resections thought to be R0 resections are R1. “Artery-first approach” is a surgical technique characterized by meticulous dissection of arterial planes and clearing of retropancreatic tissue in an attempt to achieve a higher rate of R0. To date, studies comparing AFA-PD versus ST-PD are retrospective cohort or case-control studies. [Methods]: A multicenter, randomized, controlled trial was conducted in 10 University Hospitals (NCT02803814, ClinicalTrials.gov). Eligible patients were those who presented with pancreatic head adenocarcinoma and periampullary tumors (ampulloma, distal cholangiocarcinoma, duodenal adenocarcinoma). Assignment to each group (ST-PD or AFA-PD) was randomized by blocks and stratified by centers. The primary end-point was the rate of tumor-free resection margins (R0); secondary end-points were postoperative complications and mortality. [Results]: One hundred seventy-nine patients were assessed for eligibility and 176 randomized. After exclusions, the final analysis included 75 ST-PD and 78 AFA-PD. R0 resection rates were 77.3% (95% CI: 68.4–87.4) with ST-PD and 67.9% (95% CI: 58.3–79.1) with AFA-PD, P=0.194. There were no significant differences in postoperative complication rates, overall 73.3% versus 67.9%, and perioperative mortality 4% versus 6.4%. [Conclusions]: Despite theoretical oncological advantages associated with AFA-PD and evidence coming from low-level studies, this multicenter, randomized, controlled trial has found no difference neither in R0 resection rates nor in postoperative complications in patients undergoing ST-PD versus AFA-PD for pancreatic head adenocarcinoma and other periampullary tumors. |
Databáze: | OpenAIRE |
Externí odkaz: |